NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery (Q35995828)

11 August 2017

NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery (English)

1 reference

11 August 2017

hepatocellular carcinoma

1 reference

Heng Xu

1

1 reference

11 August 2017

Na Gu

2

1 reference

11 August 2017

Zhao-Bo Liu

3

1 reference

11 August 2017

Min Zheng

4

1 reference

11 August 2017

Fang Xiong

5

1 reference

11 August 2017

Si-Ying Wang

6

1 reference

11 August 2017

Ning Li

7

1 reference

11 August 2017

Jun Lu

8

1 reference

11 August 2017

13 October 2011

1 reference

11 August 2017

1 reference

11 August 2017

3

1 reference

11 August 2017

1

1 reference

11 August 2017

39-44

1 reference

Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Global cancer statistics, 2002

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Label-free, real-time monitoring of IgE-mediated mast cell activation on microelectronic cell sensor arrays

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Expressions of cancer-testis antigens in human hepatocellular carcinomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Treatment of hepatocellular carcinoma: too many options?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

[Expression of NY-ESO-1 and LAGE-1 cancer-testis antigens in hepatocellular carcinoma].

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

The relationship between NY-ESO-1 mRNA expression and clinicopathological features in non-small cell lung cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Expression of cancer-testis genes in human hepatocellular carcinomas

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362570

Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate

23 September 2018

1 reference

12 December 2020

[Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma]

1 reference

12 December 2020

Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma

1 reference

12 December 2020

Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters

1 reference

12 December 2020

Protein expression of cancer testis antigens predicts tumor recurrence and treatment response to imatinib in gastrointestinal stromal tumors

1 reference

12 December 2020

Identifiers

DOI

10.3892/OL.2011.441

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22740853

1 reference